Nanotechnology-Driven Drug Repurposing: A Novel Strategy for Targeted Drug Delivery and Pharmacokinetic Enhancement
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 13
Special Issue Editors
Interests: drug development; small-molecule inhibitors; miRNAs; antimicrobial compounds
Special Issues, Collections and Topics in MDPI journals
Interests: peptides; peptide synthesis; natural products; pharmacognosy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology has emerged as a powerful tool in drug repurposing, offering innovative solutions for targeted drug delivery and improved pharmacokinetics. This Special Issue, Nanotechnology-Driven Drug Repurposing: A Novel Strategy for Targeted Drug Delivery and Pharmacokinetic Enhancement, explores how nanocarriers such as liposomes, nanoparticles, micelles, and exosomes can optimize the therapeutic potential of existing drugs. By leveraging nanotechnology, repurposed drugs can overcome challenges like poor bioavailability, rapid metabolism, and off-target effects, ultimately enhancing their efficacy and safety. This Special Issue welcomes original research and review articles on cutting-edge advancements in nanoformulation strategies, surface modifications for precision targeting, in vitro and in vivo studies demonstrating enhanced pharmacodynamics, and regulatory perspectives on nano-enabled drug repurposing. We particularly encourage contributions focusing on applications in oncology, infectious diseases, neurodegenerative disorders, and metabolic conditions. By bridging the gap between nanomedicine and drug repositioning, this Special Issue aims to pave the way for cost-effective and efficient therapeutic solutions for unmet clinical needs.
Dr. Christos Papaneophytou
Dr. Christos Petrou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- drug repurposing
- targeted drug delivery
- pharmacokinetics
- nanocarriers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
